NS

Narendra Shivaram Hegde

Active Director Additional Director DIN 11133648
DIN 11133648 First appointment Jun 2025 Primary industry Energy and Power
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Narendra Shivaram Hegde

Data last updated:

Narendra Shivaram Hegde is an Additional Director at Lucronics Pharmaceutical Private Limited (since 2025). The company operates in Energy and Power.

DIN 11133648
Primary Designation Additional Director
Industry Energy and Power
First Appointment 02 Jun 2025
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director02 Jun 20252022Active

Board colleagues of Narendra Shivaram Hegde

Directorship timeline

Open interactive timeline →
Lucronics Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Narendra Shivaram Hegde

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narendra Shivaram Hegde

Narendra Shivaram Hegde currently holds 1 directorship: Lucronics Pharmaceutical Private Limited (Additional Director, since 02 Jun 2025).

Narendra Shivaram Hegde was first appointed on 02 Jun 2025 as Additional Director at Lucronics Pharmaceutical Private Limited.

The current boards of Narendra Shivaram Hegde's companies include Nitin Sudhakar Joshi (Lucronics Pharmaceutical Private Limited), Prasad Narendra Kulkarni (Lucronics Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available